当前位置:
X-MOL 学术
›
Immun. Inflamm. Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma
Immunity, Inflammation and Disease ( IF 3.1 ) Pub Date : 2021-08-25 , DOI: 10.1002/iid3.513 Yuqin Qiu 1 , Xiaogang Wang 2 , Zhenjia Fan 1 , Shanhui Zhan 1 , Xin Jiang 1 , Jinchang Huang 1, 3
Immunity, Inflammation and Disease ( IF 3.1 ) Pub Date : 2021-08-25 , DOI: 10.1002/iid3.513 Yuqin Qiu 1 , Xiaogang Wang 2 , Zhenjia Fan 1 , Shanhui Zhan 1 , Xin Jiang 1 , Jinchang Huang 1, 3
Affiliation
Patients with advanced clear cell renal cell carcinoma (ccRCC) have a poor prognosis and lack effective prognostic biomarkers. N6-methyladenosine-related lncRNAs (m6A-related long noncoding RNAs [lncRNAs]) have been confirmed to be associated with the development of multiple tumors, but its role in ccRCC is not clear.
中文翻译:
透明细胞肾细胞癌中 N6-甲基腺苷相关长链非编码 RNA 预后特征、免疫检查点和免疫细胞浸润的综合分析
晚期透明细胞肾细胞癌 (ccRCC) 患者预后较差,缺乏有效的预后生物标志物。N6-甲基腺苷相关的lncRNA(m6A相关的长链非编码RNA [lncRNA])已被证实与多种肿瘤的发生有关,但其在ccRCC中的作用尚不清楚。
更新日期:2021-08-25
中文翻译:
透明细胞肾细胞癌中 N6-甲基腺苷相关长链非编码 RNA 预后特征、免疫检查点和免疫细胞浸润的综合分析
晚期透明细胞肾细胞癌 (ccRCC) 患者预后较差,缺乏有效的预后生物标志物。N6-甲基腺苷相关的lncRNA(m6A相关的长链非编码RNA [lncRNA])已被证实与多种肿瘤的发生有关,但其在ccRCC中的作用尚不清楚。